# Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba®

> **NCT01984372** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 6163 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin degludec

## Key facts

- **NCT ID:** NCT01984372
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-06
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 6163 (ACTUAL)
- **Last updated:** 2020-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01984372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01984372, "Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba®". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01984372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*